camptothecin has been researched along with bromodeoxyuridine in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 11 (55.00) | 29.6817 |
2010's | 2 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Oikawa, A; Tohda, H; Zhao, JH | 1 |
Epe, B; Hoehn, H; Poot, M | 1 |
Nagao, M; Oikawa, A; Sugimura, T; Tohda, H | 1 |
Darzynkiewicz, Z; Li, X; Traganos, F | 1 |
Darzynkiewicz, Z; Li, X; Melamed, MR | 1 |
Darzynkiewicz, Z; James, WM; Li, X; Traganos, F | 1 |
Falcieri, E; Falconi, M; Gobbi, P; Marhefka, G; Santi, S; Vitale, M; Zamai, L | 1 |
Darzynkiewicz, Z; Juan, G; Traganos, F | 1 |
Jaks, V; Jõers, A; Kristjuhan, A; Maimets, T | 1 |
Daoud, SS; Meadows, GG; Redkar, AA | 1 |
Balan, KV; Calabresi, P; Darnowski, JW; Dunaway, S; Han, Z; Hendrickson, EA; Pantazis, P; Sedivy, J; Wei, W; Wyche, JH | 1 |
Poot, M; Rabinovitch, PS; Silber, JR | 1 |
Aguirre, A; Diáz-González, F; Dorta, J; Fernández, JJ; Moser-Thier, K; Pec, MK; Souto, ML; Villar, J | 1 |
Kawada, K; Kawano, T; Miyake, S; Nagai, K; Nakajima, Y; Nishikage, T; Ogiya, K; Tanaka, K; Toukairin, Y | 1 |
Abraham, RT; Chiang, GG; Liu, YC; Mercurio, F; Otterness, DM; Xie, W; Zhang, YW | 1 |
Braun, T; Carvalho, G; Castedo, M; Coquelle, A; Kroemer, G; Métivier, D; Mouhamad, S; Pequignot, MO; Vivet, S | 1 |
Ayusawa, D; Endoh, M; Fuji, M; Hossain, MN; Miki, K | 1 |
Emond, MJ; Lauper, JM; Mao, FJ; Monnat, RJ; Sidorova, JM | 1 |
Bussom, S; Cheng, YC; Guan, F; Gullen, EA; Jiang, Z; Lam, W; Liu, SH; Zhang, W | 1 |
20 other study(ies) available for camptothecin and bromodeoxyuridine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Camptothecin-induced sister-chromatid exchange dependent on the presence of bromodeoxyuridine and the phase of the cell cycle.
Topics: Bromodeoxyuridine; Camptothecin; Cell Cycle; Cells, Cultured; Drug Interactions; Humans; Mutagens; Sister Chromatid Exchange | 1992 |
Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.
Topics: Amsacrine; Bromodeoxyuridine; Camptothecin; Cell Line; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Fanconi Anemia; Flow Cytometry; G2 Phase; Humans; Lymphocytes; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine.
Topics: Animals; Benzamides; Bromodeoxyuridine; Camptothecin; Cell Line; CHO Cells; Cricetinae; Cricetulus; DNA Replication; DNA Topoisomerases, Type I; Drug Synergism; Enzyme Activation; Ethers, Cyclic; Humans; Lymphocytes; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Phosphatase 1; Sister Chromatid Exchange | 1993 |
Simultaneous analysis of DNA replication and apoptosis during treatment of HL-60 cells with camptothecin and hyperthermia and mitogen stimulation of human lymphocytes.
Topics: Apoptosis; Bromodeoxyuridine; Camptothecin; DNA Replication; DNA, Neoplasm; Humans; Hyperthermia, Induced; Idoxuridine; Leukemia, Promyelocytic, Acute; Lymphocyte Activation; Tumor Cells, Cultured | 1994 |
Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color.
Topics: Antibodies, Monoclonal; Apoptosis; Bromodeoxyuridine; Camptothecin; Cold Temperature; Cytophotometry; Deoxycytosine Nucleotides; DNA; DNA Replication; Enzyme Inhibitors; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Lasers; Photolysis; Proliferating Cell Nuclear Antigen; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Uridine Triphosphate | 1996 |
Application of biotin, digoxigenin or fluorescein conjugated deoxynucleotides to label DNA strand breaks for analysis of cell proliferation and apoptosis using flow cytometry.
Topics: Apoptosis; Biotin; Bone Marrow; Bromodeoxyuridine; Camptothecin; Cell Division; Deoxyuracil Nucleotides; Digoxigenin; DNA; DNA Nucleotidylexotransferase; DNA Probes; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Immunohistochemistry; Indicators and Reagents; Reagent Kits, Diagnostic | 1995 |
Anti-BrdUrd labeling of newly synthesized DNA in HL-60 cells triggered to apoptosis.
Topics: Antibodies, Monoclonal; Aphidicolin; Apoptosis; Bromodeoxyuridine; Camptothecin; DNA, Neoplasm; HL-60 Cells; Humans; Time Factors; Topoisomerase I Inhibitors | 1996 |
Cell-cycle analysis of drug-treated cells.
Topics: Acids; Amsacrine; Antineoplastic Agents; Bromodeoxyuridine; Camptothecin; Cell Cycle; Cyclins; DNA; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Hot Temperature; Humans; Immunohistochemistry; Nucleic Acid Denaturation; Topoisomerase I Inhibitors | 2001 |
p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Blotting, Western; Bromodeoxyuridine; Camptothecin; Cell Cycle; Cyclin G; Cyclin G1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA Primers; DNA Replication; DNA-Directed RNA Polymerases; G1 Phase; Humans; Mice; Polymerase Chain Reaction; S Phase; Trans-Activators; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Viral Proteins | 2001 |
UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice.
Topics: Alkaloids; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bone Marrow; Bone Marrow Cells; Bromodeoxyuridine; Camptothecin; Cell Division; Colony-Forming Units Assay; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Immunoenzyme Techniques; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Protein Kinase C; Staurosporine; Topoisomerase I Inhibitors; Topotecan | 2001 |
Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta-Galactosidase; Blotting, Western; Bromodeoxyuridine; Camptothecin; Cell Cycle; Cellular Senescence; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Humans; Microscopy, Fluorescence; Models, Biological; Protein Binding; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
A novel flow cytometric technique for drug cytotoxicity gives results comparable to colony-forming assays.
Topics: 4-Nitroquinoline-1-oxide; Antimetabolites; Antineoplastic Agents, Phytogenic; Benzimidazoles; Bromodeoxyuridine; Camptothecin; Carcinogens; Cell Division; Cell Line; Cell Survival; Fibroblasts; Flow Cytometry; Fluorescent Dyes; Humans; Lymphocytes; Stem Cells; Werner Syndrome | 2002 |
Induction of apoptosis in estrogen dependent and independent breast cancer cells by the marine terpenoid dehydrothyrsiferol.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Camptothecin; Cell Cycle; Cell Division; Colchicine; DNA; Doxorubicin; Estrogens; Humans; Phosphatidylserines; Pyrans; Tumor Cells, Cultured | 2003 |
The expressions of p21 and pRB may be good indicators for the sensitivity of esophageal squamous cell cancers to CPT-11: Cell proliferation activity correlates with the effect of CPT-11.
Topics: Adenovirus E1A Proteins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Camptothecin; Carcinoma, Squamous Cell; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; DNA Topoisomerases, Type I; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Irinotecan; Nuclear Proteins; Proto-Oncogene Proteins p21(ras); Repressor Proteins; Tumor Cells, Cultured | 2004 |
Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway.
Topics: Bromodeoxyuridine; Camptothecin; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Checkpoint Kinase 1; Cullin Proteins; DNA Damage; Down-Regulation; Genes, Reporter; Humans; Proteasome Endopeptidase Complex; Protein Kinases; S Phase; Ubiquitin | 2005 |
Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis.
Topics: Apoptosis; Bromodeoxyuridine; Camptothecin; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Nitriles; Ploidies; Staurosporine; Sulfones | 2006 |
Downregulation of hnRNP C1/C2 by siRNA sensitizes HeLa cells to various stresses.
Topics: Antimetabolites; Antineoplastic Agents; Bromodeoxyuridine; Camptothecin; Diketopiperazines; Enzyme Inhibitors; Gene Expression Regulation; HeLa Cells; Herbicides; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Hydrogen Peroxide; Oxidants; Paraquat; Piperazines; RNA, Small Interfering | 2007 |
The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
Topics: Antineoplastic Agents; Bone Neoplasms; Bromodeoxyuridine; Camptothecin; Cell Growth Processes; Cell Line, Tumor; Cisplatin; DNA Damage; Exodeoxyribonucleases; Fibroblasts; Fluorouracil; Histones; Humans; Hydroxyurea; Osteosarcoma; RecQ Helicases; Werner Syndrome Helicase | 2010 |
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Biomarkers, Tumor; Bromodeoxyuridine; Camptothecin; Cell Proliferation; DNA Damage; Drugs, Chinese Herbal; Gastrointestinal Tract; Glucuronidase; Humans; Inflammation; Irinotecan; Medicine, Chinese Traditional; Mice; Proliferating Cell Nuclear Antigen; Recovery of Function; Signal Transduction; Stem Cells; Transplantation, Homologous; Weight Loss; Wnt Proteins; Wnt3 Protein; Wnt3A Protein | 2010 |